Table 3 Care pathway
Patients start immediately with mistletoe therapy | n = 202 | 19.6% |
|---|---|---|
(MT,CHRT) | 14 | 7% |
(MT,CHRT) > Surg | 23 | 11% |
(MT,CHRT,Surg) | 50 | 25% |
(MT,Surg) | 9 | 4% |
(MT,Surg) > CHRT | 23 | 11% |
MT | 50 | 25% |
MT>(CHRT,Surg) | 2 | 1% |
MT > CHRT | 3 | 1% |
MT > CHRT > Surg | 3 | 1% |
MT > Surg | 10 | 5% |
MT > Surg > CHRT | 15 | 7% |
Patients start with any type of conventional therapy | n = 816 | 79.1% |
(CHRT,Surg) > MT | 15 | 1.8% |
CHRT>(MT,Surg) | 9 | 1.1% |
CHRT > MT | 24 | 2.9% |
CHRT > MT > Surg | 5 | 0.6% |
CHRT > Surg > MT | 39 | 4.8% |
Surg>(MT,CHRT) | 333 | 40.8% |
Surg > MT | 59 | 7.2% |
Surg > MT > CHRT | 27 | 3.3% |
Surg > CHRT > MT | 305 | 37.4% |
No data1) | 13 | 1% |